COVID-19 Resources was born in March 2020 as a means of providing non-intensive care physicians with fast access to high yield resources and updates on rapidly emerging evidence as it appeared in the literature and elsewhere. As New York City was hit by the devastating first wave of the COVID-19 pandemic, it quickly became the worst mass casualty event in city history. Physicians, trainees, nurses, and other healthcare providers from all specialties were redeployed to treat and manage the influx of COVID-19 patients. Many of these incredible professionals had not previously worked in intensive care settings or treated critically ill patients. Our goals with this website were simple: to provide rapid access to the most useful resources for managing and treating these patients, to provide resources for keeping ourselves and our colleagues safe, and to build a single repository for accessing the body of knowledge and data on this disease and this virus. We believe we succeeded in this endeavor and although this pandemic is far from over, the acute need for this evidence service is over. We have gained significant proficiency in treating COVID-19 and patients are far less likely to die from the disease today than they were one year ago.
Since its inception, the footer of this website has carried the phrase “aut viam inveniam aut faciam,” “I shall either find a way or make one.” It is our firm belief that there is no greater embodiment of this saying than the incredible work that has been done to develop and deploy COVID-19 vaccines around the world in a previously unfathomable timeframe.
Given these advances in treatment and prevention, it is now time for us to return to our respective specialties. From time to time, we may post updates related to major events, but our daily updates will cease on March 10, 2021. The contents of this website will be left up and preserved to memorialize the fight against COVID-19 and the sacrifices made by healthcare workers everywhere, including the 2,900 who tragically lost their lives.